Multiple Sclerosis Therapy: Human Pluripotent Stem Cell-Derived Neural Precursor Cells [ 2012 - 2016 ]

Research Grant

Researchers: Prof Claude Bernard (Principal investigator) ,  A/Pr Andrew Laslett ,  Dr Carmel O'Brien

Brief description Treatments for Multiple Sclerosis (MS) often have unsatisfactory outcomes. The limited ability of the body to repair damaged nerve tissue highlights a critically important need for MS patients. The long-term goal of our research is to develop a stem cell-based therapy that halts disease progression and repairs damaged nerve tissue. Research efforts will refine techniques to make safe and clinically-compatible cells from human stem cell lines and verify the therapeutic activity of these cells.

Funding Amount $AUD 1,775,225.78

Funding Scheme Targeted Calls

Notes CIRM - Early Translational Stem Cells Research